India’s booming supplement industry, growing 12-15% yearly and expected to reach $18-20 billion by 2027, operates under unclear regulations that may not adequately protect consumers. According to Gram Research analysis, these products fall ambiguously between food and medicine categories, creating safety and quality concerns that experts say require stricter government oversight to ensure products are safe, effective, and honestly labeled.

India’s supplement and health product industry is booming, growing 12-15% yearly and expected to reach $18-20 billion by 2027. However, according to Gram Research analysis, these products fall into a confusing gray area between food and medicine, making it hard for regulators to ensure they’re safe and effective. A new study published in the Indian Journal of Pharmacology examines India’s current rules for these products and compares them to other countries’ approaches. The researchers argue that India needs stricter regulations to protect consumers from low-quality or unsafe supplements, especially as more people buy them online.

Key Statistics

India’s nutraceutical market expanded at a compound annual growth rate of 12-15% between 2020-2023, with the market valued at $8-10 billion in 2023, according to a 2026 policy analysis published in the Indian Journal of Pharmacology.

The Indian supplement market is projected to nearly double from $8-10 billion in 2023 to $18-20 billion by 2027, driven by increased health awareness and e-commerce growth, according to the 2026 regulatory analysis.

India currently regulates nutraceuticals under the Food Safety and Standards Act of 2006, treating them as foods rather than medicines, despite many products being sold in pharmaceutical forms like capsules and tablets with health claims.

The Quick Take

  • What they studied: How India regulates health supplements and functional foods (nutraceuticals), and whether current rules are strong enough to keep people safe
  • Who participated: This was a policy analysis and literature review, not a study with human participants. Researchers examined India’s Food Safety and Standards Act and compared it to regulations in other countries
  • Key finding: India’s supplement market is growing rapidly (12-15% per year) and will likely double in size by 2027, but the rules governing these products are unclear and may not adequately protect consumers
  • What it means for you: If you buy supplements in India, you should be cautious about quality and look for products from trusted manufacturers. The government may soon create stricter rules, which could make supplements safer but potentially more expensive

The Research Details

This research was a policy analysis and literature review, not an experiment with people. The authors examined India’s current regulatory framework for nutraceuticals—products that are supposed to be healthier versions of regular foods or supplements that claim health benefits. They looked at how India’s Food Safety and Standards Authority currently oversees these products and compared India’s approach to how other countries regulate similar items. The researchers reviewed existing rules, identified gaps and problems, and made recommendations for improvement based on international best practices.

Understanding how supplements are regulated is important because millions of Indians buy these products hoping they’ll improve their health. If regulations are weak, companies might sell products that don’t work, contain harmful ingredients, or make false claims. This research helps policymakers understand what needs to change to protect public health while still allowing the industry to grow.

This is a policy analysis and expert review rather than a scientific experiment, so it doesn’t have the same type of quality measures as clinical trials. The strength of this work depends on the authors’ expertise in regulatory law and their thorough comparison of different countries’ approaches. The article was published in a peer-reviewed medical journal, which means other experts reviewed it before publication. However, readers should understand this is an opinion-based policy analysis, not proof from testing actual products.

What the Results Show

India’s supplement industry is experiencing explosive growth, expanding at 12-15% annually between 2020-2023, with the market valued at $8-10 billion in 2023. The researchers project the market will nearly double to $18-20 billion by 2027, driven by growing interest in immunity-boosting supplements, functional foods, and online shopping. Currently, India regulates these products under the Food Safety and Standards Act of 2006, treating them as foods rather than medicines. However, the researchers found a major problem: nutraceuticals exist in a confusing middle ground between food and pharmaceutical products, making it unclear which rules should apply. Many supplements are sold in forms that look like medicines (pills, capsules, powders) and make health claims similar to drugs, creating regulatory confusion.

The analysis reveals that India’s Food Safety and Standards Authority is the main agency responsible for oversight, but their current authority and tools may be insufficient for the growing market. The researchers found that different countries handle this problem differently—some treat supplements more like drugs with stricter testing requirements, while others have created special categories specifically for nutraceuticals. The study emphasizes that as Indian companies expand globally and foreign companies enter the Indian market, quality and safety standards become even more critical. Without stronger regulations, consumers risk buying products that are contaminated, mislabeled, or ineffective.

This research builds on ongoing international discussions about how to regulate supplements. Many countries have struggled with the same problem—deciding whether supplements should follow food rules or drug rules. The researchers show that India is behind some developed nations in creating clear, specific regulations for this category. However, India’s approach of using the Food Safety and Standards Act is similar to some other countries. The key difference the authors highlight is that other nations have added more detailed requirements specifically for nutraceuticals, while India’s rules remain more general.

This is a policy analysis and literature review, not a study testing actual products or surveying consumers. The authors didn’t collect new data about supplement safety problems or consumer experiences. The research relies on existing regulations and expert opinion rather than on-the-ground evidence of how well current rules work in practice. Additionally, the regulatory landscape changes frequently, so some details may become outdated. The article doesn’t provide specific examples of unsafe products or documented harm, which would have strengthened the case for stricter regulations.

The Bottom Line

If you buy supplements in India, choose products from established manufacturers with good reputations and look for third-party testing certifications when available. The research suggests the Indian government should create stricter, clearer rules for supplements—a change that would likely improve safety but might increase prices. Consumers should be skeptical of supplements making dramatic health claims and should consult healthcare providers before starting new supplements, especially if taking medications. Confidence level: High for the need for better regulation; moderate for specific product recommendations without individual testing.

Anyone buying supplements in India should care about this research, including health-conscious consumers, parents buying supplements for children, and people managing chronic health conditions. Healthcare providers should also pay attention because their patients are likely using these products. The Indian government, supplement manufacturers, and e-commerce companies should prioritize these findings. People in other countries with similar regulatory gaps may also find this analysis relevant. However, this research is less directly applicable to people in countries with already-strict supplement regulations like the United States or European Union.

Regulatory changes typically take 1-3 years to implement after being proposed. If India strengthens its supplement rules based on this research, consumers might see changes within 2-3 years. However, even with better regulations, it takes time for manufacturers to adjust their practices and for enforcement to become consistent. Consumers shouldn’t expect immediate improvements but should watch for government announcements about new supplement regulations.

Frequently Asked Questions

Are supplements in India regulated the same way as medicines?

No. India treats supplements as foods under the Food Safety and Standards Act, not as medicines. However, researchers argue this creates confusion since many supplements are sold in pill form and make health claims similar to drugs, requiring stricter oversight.

How fast is India’s supplement industry growing?

India’s supplement market is expanding 12-15% annually and is expected to double from $8-10 billion in 2023 to $18-20 billion by 2027, driven by rising health awareness and online shopping.

What safety concerns exist with Indian supplements?

The regulatory framework is unclear about which rules apply to supplements, potentially allowing low-quality products, mislabeling, or unproven health claims. Researchers recommend stricter government regulations to ensure product safety and effectiveness.

Should I be worried about buying supplements online in India?

Exercise caution with online supplement purchases. Choose established brands, look for third-party testing certifications, and consult your doctor before starting new supplements, especially if taking medications. Stricter regulations are needed to improve online marketplace safety.

What changes does this research recommend for supplement regulation?

Experts recommend India create clearer, stricter regulations specifically for nutraceuticals—more detailed than current food rules but adapted for supplement products. This would improve quality control, safety testing, and honest labeling across the industry.

Want to Apply This Research?

  • Track which supplements you take daily, including brand name, dosage, and claimed benefits. Note any health changes you observe (energy levels, digestion, sleep quality) to help you and your doctor evaluate whether supplements are actually helping you.
  • Use the app to research supplement brands before buying—save trusted manufacturers and avoid those with unclear ingredient lists or unverified claims. Set reminders to check expiration dates and storage conditions, since poor storage can reduce supplement effectiveness.
  • Maintain a 3-month log of supplement use and health outcomes. Review quarterly to identify which supplements seem beneficial and which aren’t working. Share this data with your healthcare provider to ensure supplements don’t interact with medications and to verify they’re actually improving your health.

This article analyzes a policy review of supplement regulations in India and is not medical advice. Supplements are not tested or approved by regulatory agencies the same way medicines are. Before starting any supplement, consult with a healthcare provider, especially if you have existing health conditions, take medications, are pregnant, or breastfeeding. The regulatory landscape for supplements continues to evolve, and information in this article may change. This research does not evaluate the safety or effectiveness of specific supplement products.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Nutraceutical market in India: Thoughts on a right-based regulatory approach.Indian journal of pharmacology (2026). PubMed 42060803 | DOI